SCHEMBL5474091

SCHEMBL5474091

O=C(Nc1cccc(C(F)(F)F)c1)Nc1ccc(-c2ccc(C(=O)O)cc2)cc1-c1nnn[nH]1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 7/20 0.48
KDR P35968 6/20 0.48
CSF1R P07333 4/20 0.48
KIT P10721 4/20 0.48
FLT1 P17948 4/20 0.48
FLT3 P36888 4/20 0.48
FYN P06241 3/20 0.48
FLT4 P35916 3/20 0.48
NTRK1 P04629 3/20 0.48
NTRK2 Q16620 3/20 0.48
AURKB Q96GD4 3/20 0.48
LCK P06239 2/20 0.48
LYN P07948 2/20 0.48
BLK P51451 2/20 0.48
EPHA2 P29317 2/20 0.48
RPS6KA3 P51812 2/20 0.48
MARK2 Q7KZI7 2/20 0.48
PLK4 O00444 1/20 0.48
AURKA O14965 1/20 0.48
ROCK2 O75116 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5468806 0.93 MEN1 (0.48) GRIK1KDRCSF1RKITFLT1
SCHEMBL3577053 0.93 KDR (0.51) GRIK1KDRCSF1RKITFLT1
SCHEMBL5471427 0.92 RXFP1 (0.50) GRIK1KDRCSF1RKITFLT1
SCHEMBL5468488 0.92 KDR (0.49) KDRCSF1RKITFLT1FLT3
SCHEMBL3581371 0.90 NTRK1 (0.53) GRIK1KDRCSF1RKITFLT1
SCHEMBL5471360 0.90 RXFP1 (0.52) GRIK1KDRCSF1RKITFLT1
SCHEMBL5468768 0.88 KDR (0.45) GRIK1KDRCSF1RKITFLT1
SCHEMBL5472067 0.87 SMN1; SMN2 (0.44) KDRCSF1RKITFLT1FLT3
SCHEMBL5471923 0.87 GRIK1 (0.51) GRIK1KDRCSF1RKITFLT1
SCHEMBL5474061 0.87 KDR (0.50) KDRCSF1RKITFLT1FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070293553-A1 Diphenylurea Derivatives Useful As Potassium Channel Activators NEUROSEARCH A/S (DK) 2007-12-20 US claimed
US-20070293553-A1 Diphenylurea Derivatives Useful As Potassium Channel Activators NEUROSEARCH A/S (DK) 2007-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293553-A1 Diphenylurea Derivatives Useful As Potassium Channel Activators KCNJ2, KCNH2, KCNH3 GRIK1 216/4885KDR 1142/4885CSF1R 4006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.